Create Alert
Watchlist

Alivus Life Sciences

₹966.65
-16.60 (1.69%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
988.05
Prev. Close
983.25
Volume
23,456
Total traded value
2.27 Cr
Upper Circuit
1,179.90
Lower Circuit
786.60

Fundamentals

Market Cap₹12,055Cr
ROE17.24%
P/E Ratio(TTM)24.32
EPS(TTM)40.40
P/B Ratio4.28
Dividend Yield0.51%
Industry P/E40.64
Book Value229.65
Debt to Equity0.02
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Alivus Life Sciences

Glenmark Life Sciences is a leading developer and manufacturer of high-quality Active Pharmaceutical Ingredients (APIs), the key components used in making medicines. The company's vision is to be the most valued API player in the industry by applying science and engineering to deliver affordable, high-quality products. Its global API distribution network serves over 700 customers across more than 75 countries.;
Parent OrganisationAlivus Life Sciences
Managing DirectorDr. Yasir Rawjee
NSE SymbolALIVUS

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
74.94%
Retail And Others
13.03%
Foreign Institutions
6.42%
Mutual Funds
4.06%
Other Domestic Institutions
1.56%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
102.84
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.38
Emcure Pharmaceuticals
NA
(0.00%)
33.75
Wockhardt
NA
(0.00%)
-195.00